Nephrology and Urology

All Items

• 

  Is there an association between glomerular hyperfiltration and coronary flow velocity reserve in patients with gestational diabetes history?

  Mumtaz Takir, Ozge Telci Caklili, Fatma Betul Ozcan, Adem Atici, Mustafa Caliskan

  1345–1350
• 

  Influence of intravenous iron therapy on mortality and cardiovascular events of patients on hemodialysis: A meta-analysis

  Yan Chen, Dian Zhao, Chong Huang, Yanxia Chen, Weiping Tu, Chengyun Xu

  65–78
• 

  Increased carotid intima-media thickness in pediatric nephrotic syndrome: A meta-analysis

  Yongzheng Zhang, Mingda Song, Hai Wang, Lin Du

  399–411
• 

  Identification of novel biomarkers for lupus nephritis

  Zhengyue Liao, Liying He, Jiaojiao Fu, Xiaotong Zhou, Yong Li, Jing He, Yixin Liu, Jinlin Guo, Sijing Liu

  406–424
• 

  Frailty and survival of patients with renal cell carcinoma: A meta-analysis

  Longye Zhang, Weiping Liu, Bo Ning, Bohan Chen

  2620–2631
• 

  Effects of the CB1 receptor antagonists AM6545 and AM4113 on metabolic syndrome-induced prostatic hyperplasia in rats

  Basma G. Eid, Thikryat Neamatallah, Lenah S. Binmahfouz, Amina M. Bagher, Abdulmohsin J. Alamoudi, Hibah Mubarak Aldawsari, Abeer Hanafy, Atif Hasan, Hany M. El-Bassossy, Ashraf B. Abdel-Naim, Kiran Vemuri, Alexandros Makriyannis

  1069–1078
• 

  Donor-derived cell-free DNA as a diagnostic marker for kidney-allograft rejection: A systematic review and meta-analysis

  Yanbo Xing, Qiang Guo, Cong Wang; Haoying Shi, Jiarui Zheng, Yijun Jia; Chengyong Li, Chuan Hao

  731-740
• 

  D-box-binding protein alleviates vascular calcification in rats with chronic kidney disease by activating microRNA-195-5p and downregulating cyclin D1

  Ye Yao, Kun Zhao, Yan Zhang, Lihui Wang, Wei Shan, Xu Yan

  857-870
• 

  Curcumin and its combination with a reduced dose of rosuvastatin: A promising therapy for chronic kidney disease and associated dyslipidemia in rat animal models

  Dina Lagumdžija, Aida Hamzić Mehmedbašić, Džan Ahmed Jesenković, Bakir Kudić, Dina Kapić, Esad Ćosović, Orhan Lepara, Belma Pehlivanović Kelle, Jasminka Prguda-Mujić, Jasna Kusturica, Naida Herenda Pušina, Fahir Bečić, Aida Kulo Ćesić

  1377–1388
• 

  Comprehensive analysis of the role of interferon gamma-inducible protein 30 on immune infiltration and prognosis in clear cell renal cell carcinoma

  Xin Wen, Lei Lei, Fan Wang, Yuan Wang

  411–422
• 

  Comprehensive analysis of angiogenesis and stemness-related genes in chemotherapy and immunotherapy of bladder cancer

  Zhi-Xiang Yin, Yifan Qiu, Chenfei Xu, Changsong Pei

  2209–2228
• 

  Combined fibrinogen concentration and neutrophil-to-lymphocyte ratio, an integrative model of the inflammatory response and coagulation cascades, for predicting prognosis in patients with upper tract urothelial carcinoma

  Yangqing Zheng, Chen Chen, Chaoyue Lu, Yongxing Bao, Weishi Zhang, Haote Liang, Tingyu Ye, Zhixian Yu, Yeping Li, Lina Zhou, Deguan Yu, Binwei Lin

  1126–1137
• 

  Clinical diagnostic value of contrast-enhanced ultrasound combined with microflow imaging in benign and malignant renal tumors: A retrospective cohort study

  Xiufeng Kuang, Huiyang Wang, Weilu Chai, Huafang Yuan, Ting He, Mengya Shi, Tianan Jiang

  1370–1379
• 

  Clinical and histopathological characteristics of COL4A3 c.2881+1G>A variant causing Alport spectrum disorders in Croatian population

  Matija Horaček, Tamara Nikuševa Martić, Petar Šenjug, Marija Šenjug Perica, Maja Oroz, Sania Kuzmac, Dragan Klarić, Merica Glavina Durdov, Marijan Saraga, Danko Milošević, Danica Batinić, Marijana Ćorić, Frane Paić, Danica Galešić Ljubanović

  89-100
• 

  Circulating microRNAs in prostate cancer — Non-invasive biomarkers for diagnosis, prognosis and therapy: A review

  Ema Volar, Borna Vuković, Ivan Franin, Zrinka Madunić, Anita Bijelić, Ivana Čelap, Nino Sinčić, Igor Tomašković, Jure Murgić, Monika Ulamec
• 

  Cell division cycle 42 effector protein 4 inhibits prostate cancer progression by suppressing ERK signaling pathway

  Xiaowen Zhang, Tao Yu, Guojun Gao, Junbao Xu, Ruihui Lin, Zhifang Pan, Jianying Liu, Weiguo Feng

  840-847
• 

  Atherogenic index of plasma and risk of diabetic nephropathy in type 2 diabetes: A meta‑analysis

  Danyan Min, Junli Zhao, Miao Liu

  51–64
• 

  Association between the CRP–TyG index and lupus nephritis risk

  Baozhu Liang, Ming Tang, Junqi Huang, Yingfei Li, Rongmei Liang, Zeqing Zhai, Erwei Sun
• 

  Artificial intelligence in renal pathology: Current status and future

  Chunyue Feng, Fei Liu

  225–234
• 

  Arbutin as a potential nephroprotective agent: Dose-related effects in renal ischemia-reperfusion injury

  Ferhat Sirinyildiz, Izel Kavak, Nesibe Kahraman Cetin, Adem Keskin

  462–470